Skip to content

Traction method versus conventional endoscopic submucosal dissection for gastric epithelial neoplasms

Traction method versus conventional endoscopic submucosal dissection for gastric epithelial neoplasms - Traction method versus conventional endoscopic submucosal dissection for gastric epithelial neoplasms

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044450
Enrollment
150
Registered
2021-06-06
Start date
2021-06-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric epithelial neoplasia

Interventions

Endo Trac ESD group Conventional ESD group

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)over 20 years old 2)gastric epihelial tumor that is ESD-adaptive by endoscopy in accordance with the 2020 ESD/EMR guideline for gastric cancer 3)performance status 0-2 4)obtained written informed consent after appropriate explanation prior to study

Exclusion criteria

Exclusion criteria: 1)tumor suspected of deep submucosal invasion 2)tumor diagnosed as not gastric epithelial tumor pathologically 3)whole invisible tumor 4)tumor crossing the esophagogastric junction or the pylorus ring 5)ESD management of over double tumor 6)history of gastrectomy or reconstructive surgery of the gastric tract 7)easy bleeding 8)using over two antiplatelet or an anticoagulant medication 9)severe disease in other organs by ASA classification over class 4 10)pregnancy 11)any other reasons for ineligibility to investigator judgement

Design outcomes

Primary

MeasureTime frame
ESD procedure time

Secondary

MeasureTime frame
1)ESD procedure time according to the proficiency of the operator(trainee or expert),tumor size ,the location of the lesion, the presence of ulcer findings and institutions 2)Equipping time of Endo Trac 3)Procedure time from starting traction by Endo Trac to complete 4)Clip slip-off rate during Endo Trac ESD ,number of Endo Trac used 5)Conversion rate 6)Traction-related damage rate to specimen 7)Histologic evaluation(en bloc resection rate, curative resection rate, depth of tumor ,size of specimen and tumor) 8)Adverse events

Countries

Japan

Contacts

Public ContactJun Kinoshita

Wakayama Medical University Hospital Gastroenterology

jun@wakayama-med.ac.jp073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026